X

Stay Connected

Sign Up for Updates

 
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.
Tiffany Haverly

Tiffany Haverly Tiffany Haverly is a former director, public affairs, at PhRMA.

Recent Posts

ICYMI: Canadian government, stakeholders voice concerns with drug importation proposals

By Tiffany Haverly  |    August 1, 2019
This week, the U.S. Department of Health and Human Services and the U.S. Food and Drug Administration announced their “Safe Importation Action Plan.” While patients are rightfully concerned about the...   Read More

PhRMA responds to Florida’s request for information on drug importation

By Tiffany Haverly  |    June 26, 2019
PhRMA remains committed to working with lawmakers to ensure patients can afford and access their medicines, but importation schemes that put patient safety at risk will never be the right approach.   Read More

PhRMA CEO raises concerns with Florida importation proposal, highlights reforms needed to lower costs for patients

By Tiffany Haverly  |    May 8, 2019
PhRMA is committed to working with lawmakers to ensure patients can access and afford their medicines, but importation schemes that put patient safety at risk are the wrong approach. In a recent...   Read More

New data show how sharing negotiated discounts could save certain patients hundreds of dollars at the pharmacy counter

By Tiffany Haverly  |    February 25, 2019
Updated 3/5/2019 Ensuring patients receive already negotiated savings on their medicines could save certain patients across seven states up to $2,360 a year, according to new analyses from Milliman.   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates